In our study, we found that irisin was downregulated post-CCH, and increasing its endogenous production facilitated its binding to the integrin αVβ5 receptor and the subsequent activation of the downstream AMPK pathway [34, 81, 82]. Here, FNDC5 is linked to columnar cell hyperplasia of the breast.